Strong Thromboxane Synthase Inhibitors 99% Ozagrel CAS 82571-53-7

• Powder: Yes
• Customized: Non-Customized
• Certification: GMP, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: Solid
• Purity: >99%
• Grade: Pharmaceutcial Grade
• CAS: 82571-53-7
• Storage: Cool Dry Place
• Deliver Time: 5-10 Days
• Appearance: White Powder
• Test Method: HPLC UV
• Sample: Available
• Shipping Method: Air(UPS, FedEx, TNT, EMS) or Sea
• Mf: C13h12n2o2
• COA: Available
• MOQ: 50 Grams
• Transport Package: Bag or Drum
• Specification: 1kg/bag 25kg/drum
• Origin: China
• Production Capacity: 10000kg/Months

Product Description

Product Description

Product Name:	Ozagrel
Synonyms:	(2E)-3-[4-(1H-Imidazol-1-ylmethyl)phenyl]acrylic acid; (E)-3-[4-(1H-Imidazol-1-ylmethyl)phenyl]-2-propenoic Acid; (E)-4-(Imidazol-1-ylmethyl)cinnamic Acid; 2-propenoic acid, 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-, (2E)-; 82571-53-7; Xanbon; (2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]prop-2-enoic acid
CAS RN.:	82571-53-7
Molecular Weight:	228.2466
Molecular Formula:	C13H12N2O2
Density:	1.17g/cm3
Boiling Point(ºC):	468°C at 760 mmHg
Flash Point(ºC):	236.8°C
refractive_index:	1.593

Ozagrel, an antithrombic drug, is a potent and selective TXA Synthase (thromboxane A2) inhibitor highly active in human platelets. Found to induce apoptosis in T24 and TCC-SUP bladder cancer cells. Ozagrel improved locomotor activity and coordination in ischemia-reperfusion injured mice models and has potential therapeutic usage for stroke. Reported to inhibit pulmonary thromboxane B2 delivery blocking the increase in systemic vascular resistance. Also shown to inhibit phenolase activities of mushroom tyrosinase.

Detailed Photos

 

 

Items	Standard
Appearance	White to off-white crystalline powder
Assay	98.5%min
Chloride	0.02%max
Ammonium	0.02%max
Sulfate	0.02%max
Iron	10ppm max
Heavy metals	10ppm max
Arsenic	1ppm max
Other amino acids	Chromatographically not detectable
Loss on drying	0.2% max
Residue on ignition	0.1%

Function and Application

A strong thromboxane synthetase inhibitor. By inhibiting thromboxane synthetase, reducing thromboxane A, (TXA2), and promoting the formation of prostacyclin (PGl2), to antagonize platelet aggregation and cerebral vasospasm, and almost no effect on other arachidic acid metabolizing enzymes such as cyclooxygenase. It is used for cerebral vasospasm after subarachnoid hemorrhage and cerebral ischemia accompanied by cerebral spasm and improvement of movement disorder accompanied by acute cerebral thrombosis.

Packaging & Shipping

Company Profile

Shandong Longilat Biotechnology Co., Ltd was established in 2015. It is a high-tech professional and technological enterprise integrating R & D, production, and sales. 

Longilat 's main products are food additives, plant extracts, cosmetic raw materials, feed additives, animal extract, amino acids and vitamins. Most of our products are derived from natural plants. Marketing services are available in many countries around the world. 

FAQ

1.Can I get some samples?
Yes, usually a 10-20g sample.

2.What's your MOQ?
Our MOQ is flexible, usually 1kg-10kg for a trial order is acceptable.

3. Is there a discount?
Of course, welcome to contact us. Price would be different based on different quantities. For bulk quantity, we will have a discount for you.

4. How to deliver the goods?
≤50kg ship by FedEx or DHL etc, ≥50kg ship by Air, ≥100kg can be shipped by Sea. If you have special request on delivery, please contact us.

5. What is the shelf life for the products?
Most products shelf life 24-36 months. 

6. What's your delivery time?
Usually, shipment will be made within 7-15 days against confirmed order.

7. How about the validity of the offer? 
Usually, our offer is valid for 1 week. However, validity might vary between different products.